Progyny, Inc. Announces Details for Its Second Quarter Results Report
Progyny (Nasdaq: PGNY) will announce its financial results for the quarter ending June 30, 2020, on August 5, 2020. The report will be released after market close, followed by a conference call at 4:45 PM ET.
Participants can access the call by dialing specific numbers for U.S. and international attendees. An audio replay will be available until August 11, 2020. Progyny, a leader in fertility benefits management, emphasizes a comprehensive approach that supports employers and patients alike.
- Well-established as a leader in fertility benefits management.
- Upcoming financial results announcement may indicate growth and performance.
- None.
NEW YORK, July 22, 2020 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, will report its financial results for the quarterly period ended June 30, 2020 after the close of the market on Wednesday, August 5, 2020.
The company will host a conference call at 4:45 P.M. Eastern Time (1:45 P.M. Pacific Time) and issue a press release regarding its financial results prior to the start of the call.
Interested participants in the United States may access the conference call by dialing 1.877.883.0383 and using the passcode 4278956. International participants may access the call by dialing 1.412.902.6506 and using the same passcode.
An audio replay of the call will be available through Tuesday, August 11, 2020 and may be accessed by dialing 1.877.344.7529 (U.S. participants) or 1.412.317.0088 (international participants) with the passcode 10146608.
A live webcast and archive of the call will be available from the Events and Presentations section of the Company’s website at http://investors.progyny.com.
About Progyny
Progyny (Nasdaq: PGNY) is a leading fertility benefits management company in the US. We are redefining fertility and family building benefits, proving that a comprehensive and inclusive fertility solution can simultaneously benefit employers, patients, and physicians.
Our benefits solution empowers patients with education and guidance from a dedicated Patient Care Advocate (PCA), provides access to a premier network of fertility specialists using the latest science and technologies, reduces healthcare costs for the nation’s leading employers, and drives optimal clinical outcomes. We envision a world where anyone who wants to have a child can do so.
Headquartered in New York City, Progyny has been recognized for its leadership and growth by CNBC Disruptor 50, Modern Healthcare’s Best Places to Work in Healthcare, Financial Times, INC. 5000, and Crain’s Fast 50 for NYC. For more information, visit www.progyny.com.
For Further Information, Please Contact:
Investors:
James Hart
investors@progyny.com
Media:
Selena Yang
media@progyny.com
FAQ
When will Progyny report its Q2 2020 financial results?
What is the time for the Progyny conference call?
How can I access the Progyny conference call?
Is there a replay available for the Progyny conference call?
